Global Medical Manager
LEO Pharma
92210, Saint-Cloud, Ile-de-France, France
Dr. Nicolas Janus was graduated as a PharmD, clinical research and biostatisitics in 2005 and 2006 and started to practice at the Nephrology department of the Pitié-Salpêtrière Hospital in Paris (France). He also joined "Service ICAR" which is a medical advisory service on "drugs and the kidney" ie. 1) drug dosage adjustment in patients with renal disease, 2) drug-drug interactions with immunosuppressive, and 3) drugs renal effects. Dr Janus also co-authored the siteGPR.com website that provide drug dosage adjustment in patients with renal insufficiency and worked with Bayer, Baxter, Boehringer-Ingelheim, BBRAUN, Daichii-Sankyo, Gilead, Guerbet, Fresenius, IPSEN, TEVA, LEO Pharma, Pfizer, Pierre Fabre and Vifor Pharma.
Main field of interest were nephrotoxicology, nephropharmacology, Vaccine/Infection Dis., Oncology, Cardiology and of course Thrombosis.
In 2017, Dr Janus left the hospital and moved to LEO Pharma and joined the Global Thrombosis Strategy department as Global Medical Manager.
Dr Janus is/was a member of EFP: Member 2007-2017, President 2012-2016; EAHP: Member from 2011-2017, Scientific Committee from 2012-2014; SFNDT: Member since 2013; French Society of Cardiology: Member 2015-2017; AFSOS: Member since 2012; ESCP: Member 2006-2011; MASCC: Member since 2016; ESMO: Member since 2016; ISTH: Member since 2017; ASH: Member since 2020; GRIFON: Member since 2023.
Dr. Janus has authored 55 articles (PubMed), 30 articles/chapters/books (not on Pubmed), 164 communications in congresses from 2006.
h-index: 21
Favourite expressions:
"Simplicity is the top of elegance"
"A mountain always look higher before starting to climb and less high when you are climbing"
"Even when I am sure to know something, I always learn more by listening to other"
PO30 - GastroIntestiNal toxicities induced by Anticancer drugs (GINA) used lung cancer.
Wednesday, June 28, 2023
13:00 – 14:00 ET
PO42 - Thrombocytopenia Induced by ANticancer Agents (TIANA) in lung cancer.
Wednesday, June 28, 2023
13:00 – 14:00 ET